Cargando…
Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery
The field of myocardial regeneration utilizing novel cell-based therapies, gene transfer, and growth factors may prove to play an important role in the future management of ischemic heart disease and cardiomyopathy. Phases I and II clinical trials have been published for a variety of biologics utili...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047684/ https://www.ncbi.nlm.nih.gov/pubmed/21181320 http://dx.doi.org/10.1007/s12265-010-9253-z |
_version_ | 1782199056850747392 |
---|---|
author | Dib, Nabil Khawaja, Harris Varner, Samantha McCarthy, Megan Campbell, Ann |
author_facet | Dib, Nabil Khawaja, Harris Varner, Samantha McCarthy, Megan Campbell, Ann |
author_sort | Dib, Nabil |
collection | PubMed |
description | The field of myocardial regeneration utilizing novel cell-based therapies, gene transfer, and growth factors may prove to play an important role in the future management of ischemic heart disease and cardiomyopathy. Phases I and II clinical trials have been published for a variety of biologics utilizing four methods of delivery: systemic infusion, intracoronary infusion, transvenous coronary sinus, and intramyocardial. This review discusses the advantages and disadvantages of the delivery approaches above. |
format | Text |
id | pubmed-3047684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-30476842011-04-05 Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery Dib, Nabil Khawaja, Harris Varner, Samantha McCarthy, Megan Campbell, Ann J Cardiovasc Transl Res Article The field of myocardial regeneration utilizing novel cell-based therapies, gene transfer, and growth factors may prove to play an important role in the future management of ischemic heart disease and cardiomyopathy. Phases I and II clinical trials have been published for a variety of biologics utilizing four methods of delivery: systemic infusion, intracoronary infusion, transvenous coronary sinus, and intramyocardial. This review discusses the advantages and disadvantages of the delivery approaches above. Springer US 2010-12-23 2011 /pmc/articles/PMC3047684/ /pubmed/21181320 http://dx.doi.org/10.1007/s12265-010-9253-z Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Dib, Nabil Khawaja, Harris Varner, Samantha McCarthy, Megan Campbell, Ann Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery |
title | Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery |
title_full | Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery |
title_fullStr | Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery |
title_full_unstemmed | Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery |
title_short | Cell Therapy for Cardiovascular Disease: A Comparison of Methods of Delivery |
title_sort | cell therapy for cardiovascular disease: a comparison of methods of delivery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047684/ https://www.ncbi.nlm.nih.gov/pubmed/21181320 http://dx.doi.org/10.1007/s12265-010-9253-z |
work_keys_str_mv | AT dibnabil celltherapyforcardiovasculardiseaseacomparisonofmethodsofdelivery AT khawajaharris celltherapyforcardiovasculardiseaseacomparisonofmethodsofdelivery AT varnersamantha celltherapyforcardiovasculardiseaseacomparisonofmethodsofdelivery AT mccarthymegan celltherapyforcardiovasculardiseaseacomparisonofmethodsofdelivery AT campbellann celltherapyforcardiovasculardiseaseacomparisonofmethodsofdelivery |